July 19 (Reuters) - Genoway SA ALGEN.PA :
* H1 REVENUE EUR 6.2 MILLION VERSUS EUR 4.8 MILLION YEAR AGO
* OUR AMBITION TO REACH A TURNOVER OF €30 MILLION BY 2024 ARE REFLECTED IN
H1
SALES
* SEES H2 GROWTH AS EQUIVALENT TO H1
* WE PLAN TO EXPAND SALES TEAMS TO MEET CURRENT DEMAND WHILE CONTINUING OUR
BUSINESS DEVELOPMENT EFFORTS AND INCREASING PRESENCE AT SEMINARS DEDICATED TO
PRE-CLINICAL RESEARCH MODELS IN IMMUNO-ONCOLOGY
Source text for Eikon: ID:nNDL5sh9fZ
Further company coverage: ALGEN.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))